Avertix Medical develops implantable cardiac surveillance devices for early detection and patient alerting of acute coronary syndrome (ACS), including silent heart attacks. Its flagship product, the Avertix Guardian™, is an FDA‑cleared implantable system intended to warn patients and notify clinicians to prompt timely medical evaluation, supporting long‑term management of advanced cardiovascular disease across physicians, health systems, and allied health professionals.
Leadership & Board
Current Number of Employees41
Current LinkedIn Followers3,522
Employee Trend
Avertix Medical had 41 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
41Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Avertix Medical had 3,522 followers as of April 6, 2026. The number of followers increased by 2 (0.06%) week-over-week.
3,522Latest Followers Count
2(0.06%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.